Depression anxiety and antidepressant treatment in women Association with in vitro fertilization outcome

Capsule:
A diagnosis of depression, anxiety, or treatment with antidepressants before an in vitro fertilization cycle had a slight negative association with pregnancy and live birth but not miscarriage.

Authors:
Carolyn E. Cesta, M.Sc., Alexander Viktorin, Ph.D., Henrik Olsson, M.Sc., Viktoria Johansson, Ph.D., Arvid Sjölander, Ph.D., Christina Bergh, M.D., Alikistis Skalkidou, Ph.D., Karl-Gösta Nygren, M.D., Sven Cnattingius, Ph.D., Anastasia N. Iliadou, Ph.D.

Volume 105, Issue 6, Pages 1594-1602

Abstract:

Objective:
To investigate associations between depression, anxiety, and antidepressants before in vitro fertilization (IVF) and IVF cycle outcomes, including pregnancy, live birth, and miscarriage.

Design:
Nationwide register-based cohort study.

Setting:
Not applicable.

Patient(s):
Nulliparous women undergoing their first IVF cycle recorded in the Swedish Quality Register of Assisted Reproduction, January 2007 to December 2012 (n = 23,557).

Intervention(s):
Not applicable.

Main Outcome Measure(s):
Associations between diagnoses of depression/anxiety, antidepressants, and IVF cycle outcome evaluated using logistic regression to produce adjusted odds ratios (AOR) and 95% confidence intervals (CI).

Result(s):
In total, 4.4% of women had been diagnosed with depression/anxiety and/or dispensed antidepressants before their IVF first cycle. The odds for pregnancy and live birth were decreased (n = 1,044; AOR = 0.86; 95% CI, 0.75–0.98; and AOR = 0.83; 95% CI, 0.72–0.96, respectively). For women with a prescription for a selective serotonin reuptake inhibitor (SSRI) only (n = 829), no statistically significant associations were found. Women with non-SSRI antidepressants (n = 52) were at reduced odds of pregnancy (AOR = 0.41; 95% CI, 0.21–0.80) and live birth (AOR = 0.27; 95% CI, 0.11–0.68). Women with a depression/anxiety diagnosis with no antidepressant (n = 164) also had reduced odds of pregnancy (AOR = 0.58; 95% CI, 0.41–0.82) and live birth (AOR = 0.60; 95% CI, 0.41–0.89). Among the women who became pregnant (39.7%), there were no statistically significant associations between exposure and miscarriage except for the women taking non-SSRI antidepressants (AOR = 3.56; 95% CI, 1.06–11.9).

Conclusion(s):
A diagnosis of depression/anxiety and/or treatment with antidepressants before IVF was slightly associated with reduced odds of pregnancy and live birth. Women with the presence of depression/anxiety without antidepressants had a more pronounced reduction in odds, implying that the underlying disorder is important for the observed association.

Translate »